APA (7th ed.) Citation

Samarin, J., Nůsková, H., Fabrowski, P., Malz, M., Amtmann, E., Täubert, M. J., . . . Gunkel, N. (2026). Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy. Nature Communications, 17, . https://doi.org/10.1038/s41467-026-71608-4

Chicago Style (17th ed.) Citation

Samarin, Jana, et al. "Differential KEAP1/NRF2 Mediated Signaling Widens the Therapeutic Window of Redox-targeting Drugs in SCLC Therapy." Nature Communications 17 (2026). https://doi.org/10.1038/s41467-026-71608-4.

MLA (9th ed.) Citation

Samarin, Jana, et al. "Differential KEAP1/NRF2 Mediated Signaling Widens the Therapeutic Window of Redox-targeting Drugs in SCLC Therapy." Nature Communications, vol. 17, 2026, https://doi.org/10.1038/s41467-026-71608-4.